EUCTR2012-004892-37-NL进行中(未招募)1 期
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell disease - NAC Trial
Academic Medical Center0 个研究点目标入组 140 人开始时间: 2013年3月21日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age 12 years or older
- •-Sickle cell disease, either homozygous sickle cell disease (HbSS), HbSC sickle cell
- •disease, HbSß0 or HbSß+ thalassemia.
- •Genotype needs to be confirmed by high performance liquid chromatography.
- •-History of at least 1.0 painful crisis per year in the past 3 years.
- •A crisis will be defined here as a patient defined, painful, sickle cell related episode of at least 24 hours where a subject experienced significant impediments in his/her daily activities, and pain medication had to be taken. A visit to a medical facility is not obligatory in this definition.
- •-Written informed consent from patient/parent/guardian is given.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 30
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •-Chronic blood transfusion or transfusion in the preceding 3 months
- •-Painful crisis in the last 4 weeks (with respect to the moment of inclusion).
- •A crisis will be defined as above; a patient defined, painful, sickle cell related episode of at least 24 hours where the subject experienced significant impediments in his/her daily activities, and pain medication had to be taken. A visit to a medical facility is not obligatory in this definition.
- •-Pregnancy, breast feeding or the desire to get pregnant in the following 7 months
- •-Known active gastric/duodenal ulcers
- •-Hydroxycarbamide (HC) treatment with unstable dose in the last 3 months or started on
- •HC shorter then 6 months prior to study.
- •-Known poor compliance in earlier trials regarding the completion of pain diaries.
- •-Insufficient compliance in run-in period.
- •Participants that do not show up for their follow-up visit without prior notice, that not bring
- •their diary or with less than 80% of the days in the pain diary filled in, will be excluded from participation in this trial and will not be randomized.
研究者
相似试验
进行中(未招募)
不适用
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseMedDRA version: 17.1Level: LLTClassification code 10002077Term: Anaemia sickle cellSystem Organ Class: 100000004850MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Sickle Cell DiseaseEUCTR2012-004892-37-GBAcademic Medical Center, Department of Haematology, University of Amsterdam140
进行中(未招募)
1 期
Acetylcysteine in patients with Sickle Cell Disease: Reducing the incidence of daily life pain in patients with sickle cell diseaseEUCTR2012-004892-37-BEAcademic Medical Center140
招募中
不适用
Acetylcysteine in Patients With Sickle Cell Disease (NAC).Sickle Cell DiseaseSickle Cell AnemiaPainful CrisisPainSikkelcel ziekteSikkelcel anemiePijnlijke crisePijnNL-OMON28196Academic Medical Center, Amsterdam140
尚未招募
不适用
Acetylcysteine for Treatment of Sickle Cell Diseasesickle cell disease10018902NL-OMON30544Academisch Medisch Centrum10
进行中(未招募)
不适用
Acetylcysteine for Treatment of Sickle Cell Disease - N-acetylcystein for Sickle Cell DiseasePatients homozygous for sickle cell diseaseMedDRA version: 8.1Level: LLTClassification code 10040644Term: Sickle cell diseaseEUCTR2006-005889-40-NLAcademic Medical Centre10
